Literature DB >> 3489936

Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

A Rein, M R McClure, N R Rice, R B Luftig, A M Schultz.   

Abstract

It was previously reported that the gag proteins of mammalian type C retroviruses are modified by the addition of myristate to the N-terminal glycine residue. We have performed oligonucleotide-directed mutagenesis to change this glycine codon in the Moloney murine leukemia virus genome to an alanine codon and also to specifically delete the glycine codon. Upon transfection into mammalian cells, these mutant genomes direct the synthesis of gag proteins, but these proteins are not myristylated. The mutants do not form virus particles or any recognizable virus-specific structures visible in thin sections with the electron microscope. Further, the mutant gag proteins appear to remain in the cytosol, whereas the wild type is found principally in particulate fractions of the cell. The results are consistent with the theory that myristate is required for the association of the gag protein with the plasma membrane and that this association is necessary for virus assembly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489936      PMCID: PMC386692          DOI: 10.1073/pnas.83.19.7246

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Comparative study of different isolates of murine sarcoma virus.

Authors:  D J Donoghue; P A Sharp; R A Weinberg
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Rescue and transmission of a replication-defective variant of moloney murine leukemia virus.

Authors:  A Rein; B M Benjers; B I Gerwin; R H Bassin; D R Slocum
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

4.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

5.  Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

Authors:  R J Versteegen; S Oroszlan
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene.

Authors:  A M Schultz; E H Rabin; S Oroszlan
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

8.  Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule.

Authors:  B I Gerwin; A Rein; J G Levin; R H Bassin; B M Benjers; S V Kashmiri; D Hopkins; B J O'Neill
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

9.  Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells.

Authors:  D R Lowy; E Rands; S K Chattopadhyay; C F Garon; G L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  177 in total

1.  PR domain of rous sarcoma virus Gag causes an assembly/budding defect in insect cells.

Authors:  M C Johnson; H M Scobie; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

4.  Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

Authors:  J B Bowzard; R J Visalli; C B Wilson; J S Loomis; E M Callahan; R J Courtney; J W Wills
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution.

Authors:  D R Johnson; A D Cox; P A Solski; B Devadas; S P Adams; R M Leimgruber; R O Heuckeroth; J E Buss; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids.

Authors:  Maria C Silva; Qian-Chun Yu; Lynn Enquist; Thomas Shenk
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly.

Authors:  Rachael M Crist; Siddhartha A K Datta; Andrew G Stephen; Ferri Soheilian; Jane Mirro; Robert J Fisher; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.